Dear editor of Obesity Surgery,
Dear editor of Obesity Surgery,
We have read with interest the review article written by Cardinelli et al., where the microbiota's mechanisms, which influence weight gain, are addressed [1] .
We consider that this approach provides important information on the current role of intestinal microbiota in weight regulation and we think that this knowledge is highly relevant to understand the impact made on this bacterial community when a surgery, that disrupts the gastrointestinal tract, is performed on an obese patient and how this affects the energy balance and weight changes.
Nevertheless, we would like to add some topics that are crucial for understanding how the gut microbiota is related to the changes in the energy metabolism, which we think was not fully addressed in the article.
The article only explains the effect of the SREBP-1 on the lipid metabolism and the effects of the SREBP-2 were not addressed. On this matter, a study by Caesar et al. [2] performed on two groups of mice fed with lard or fish oil, in addition to an isocaloric diet, studied the interaction between the dietary lipids and the composition of the liver and serum lipids.
The main result was that the gut microbiota in lard-fed mice induced an increase of cholesteryl ester species in the liver mainly by the down regulation of genes associated with the cholesterol biosynthesis in this organ.
On this matter, the enzymes implied in the mevalonate pathway, HMG-CoA reductase being the most important one, and the steroid biosynthesis were the most affected pathways in the studied mice.
In addition, the same study found that the cleaved bioactive form of the SREBP-2 gene, which regulates the activation of cholesterol biosynthesis in the liver [3] , was decreased in comparison to the expression of this gene-meaning that the SREBP-2 and the levels of hepatic cholesterol have an inverse relation [2] .
The importance of this is the implication that the microbiota plays an important role in the accumulation of fat in the liver mediated by the mechanism previously described and; therefore, could be involved in non-alcoholic fatty liver disease.
Obesity has multiple treatments both clinical and surgical; however, bariatric surgery is the one that has had better sustained and long-term results [4] ; although, it generates a great change both at the hormonal level (elevated Leptin) as well as in the gut microbiota [5] . The article states that humans who underwent Roux-Y gastric bypass (RYGB) developed high levels of leptin, but low levels of Bacteroides, Prevotella and Escherichia coli.
These changes, however, appear to have improved body weight loss and decreased the number of adipocytes. The same results were found when the intestinal microbiota was transferred from mice treated with RYGB to non-operated ones [6] .
Thus, the article concludes microbiota is altered in both operated and non-operated obese subjects. We agree with the conclusions given, since there is a change in the gut microbiota after bariatric surgery in its composition and/or in its richness [5] .
These findings were similar to a study made by Tremaroli et al. [6] , in which the intestinal microbiota was analysed by Shotgun Sequencing in women who underwent bariatric surgery type RYGB and vertical band gastroplasty (VBG). The main result of this study was the confirmation of weight and fat loss after either surgery [6] . Likewise, it was also concluded that both surgeries generate long-term effects in
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Augusto Rafael Fernandez-Aristi pcmerfer@gmail.com the composition of the gut microbiota, such as decreased levels of Firmicutes in women who underwent RYGB. On this matter, it is important to highlight that there were no differences in microbiota profiles in patients who underwent either VBG or RYGB [6] . For all of the above, we agree that obesity generates a change in the gut microbiota, which plays an important role in its pathophysiology. Nevertheless, bariatric surgery also generates an alteration of the gut microbiota but with a more beneficial outcome for the patient, such as a decrease of future gut infections. For these reasons, it is important to do further research about obesity-related gut microbiota.
Finally, the reason for this letter was to highlight two issues that we, as readers, think were not fully addressed in the review, and our main interest is to give more information on how the microbiota affects the lipid metabolism in obesity and how it changes when a patient undergoes metabolic surgery.
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